Figure 5.

MG‐ADL and MG‐QOL15 in the immunotherapy subgroups at sign‐up. Mean and 95% confidence intervals for MG‐ADL and MG‐QOL15 measured at entry into the MGR for immunotherapy subgroups based on their self‐reported current or past medication use. Black vertical lines indicate overall means and 95% confidence intervals for the entire study sample, irrespective of therapy. MG‐ADL, Myasthenia Gravis—Activities of Daily Living; MG‐QOL15, 15‐item Myasthenia Gravis Quality of Life; MGR, Myasthenia Gravis Patient Registry